Literature DB >> 16549792

Directed antigen delivery as a vaccine strategy for an intracellular bacterial pathogen.

H G Archie Bouwer1, Christine Alberti-Segui, Megan J Montfort, Nathan D Berkowitz, Darren E Higgins.   

Abstract

We have developed a vaccine strategy for generating an attenuated strain of an intracellular bacterial pathogen that, after uptake by professional antigen-presenting cells, does not replicate intracellularly and is readily killed. However, after degradation of the vaccine strain within the phagolysosome, target antigens are released into the cytosol for endogenous processing and presentation for stimulation of CD8(+) effector T cells. Applying this strategy to the model intracellular pathogen Listeria monocytogenes, we show that an intracellular replication-deficient vaccine strain is cleared rapidly in normal and immunocompromised animals, yet antigen-specific CD8(+) effector T cells are stimulated after immunization. Furthermore, animals immunized with the intracellular replication-deficient vaccine strain are resistant to lethal challenge with a virulent WT strain of L. monocytogenes. These studies suggest a general strategy for developing safe and effective, attenuated intracellular replication-deficient vaccine strains for stimulation of protective immune responses against intracellular bacterial pathogens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16549792      PMCID: PMC1458801          DOI: 10.1073/pnas.0509381103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Cutting edge: rapid in vivo killing by memory CD8 T cells.

Authors:  Daniel L Barber; E John Wherry; Rafi Ahmed
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

2.  Sustained response initiation is required for T cell clonal expansion but not for effector or memory development in vivo.

Authors:  Leo Lefrançois; Amanda Marzo; Kristina Williams
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

Review 3.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

4.  Priming of memory but not effector CD8 T cells by a killed bacterial vaccine.

Authors:  G Lauvau; S Vijh; P Kong; T Horng; K Kerksiek; N Serbina; R A Tuma; E G Pamer
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

5.  A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy.

Authors:  K J Radford; D E Higgins; S Pasquini; E J Cheadle; L Carta; A M Jackson; N R Lemoine; G Vassaux
Journal:  Gene Ther       Date:  2002-11       Impact factor: 5.250

6.  Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors.

Authors:  Peter Lauer; Man Yin Nora Chow; Martin J Loessner; Daniel A Portnoy; Richard Calendar
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

7.  Requirement of the Listeria monocytogenes broad-range phospholipase PC-PLC during infection of human epithelial cells.

Authors:  Angelika Gründling; Mark D Gonzalez; Darren E Higgins
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

8.  Escherichia coli expressing recombinant antigen and listeriolysin O stimulate class I-restricted CD8+ T cells following uptake by human APC.

Authors:  Paul Q Hu; Renee J Tuma-Warrino; Marianne A Bryan; Kathleen G Mitchell; Darren E Higgins; Simon C Watkins; Russell D Salter
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

9.  Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells.

Authors:  Anthony M Byers; Christopher C Kemball; Janice M Moser; Aron E Lukacher
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

10.  Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation.

Authors:  Haroula Angelakopoulos; Katharina Loock; David M Sisul; Eric R Jensen; Jeff F Miller; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  6 in total

Review 1.  Large screen approaches to identify novel malaria vaccine candidates.

Authors:  D Huw Davies; Patrick Duffy; Jean-Luc Bodmer; Philip L Felgner; Denise L Doolan
Journal:  Vaccine       Date:  2015-10-01       Impact factor: 3.641

2.  Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications.

Authors:  James S Testa; Ramila Philip
Journal:  Future Virol       Date:  2012-11-01       Impact factor: 1.831

3.  Differential functional patterns of memory CD4+ and CD8+ T-cells from volunteers immunized with Ty21a typhoid vaccine observed using a recombinant Escherichia coli system expressing S. Typhi proteins.

Authors:  Rosângela Salerno-Gonçalves; Hervé Tettelin; David Luo; Qin Guo; Matthew T Ardito; William D Martin; Anne S De Groot; Marcelo B Sztein
Journal:  Vaccine       Date:  2019-10-16       Impact factor: 3.641

4.  Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIV.

Authors:  James B Whitney; Saied Mirshahidi; So-Yon Lim; Lauren Goins; Chris C Ibegbu; Daniel C Anderson; Richard B Raybourne; Fred R Frankel; Judy Lieberman; Ruth M Ruprecht
Journal:  J Immune Based Ther Vaccines       Date:  2011-01-18

5.  Protective immunity to Listeria monocytogenes infection mediated by recombinant Listeria innocua harboring the VGC locus.

Authors:  Walid Mohamed; Shneh Sethi; Svetlin Tchatalbachev; Ayub Darji; Trinad Chakraborty
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

6.  Use of a novel antigen expressing system to study the Salmonella enterica serovar Typhi protein recognition by T cells.

Authors:  Rosângela Salerno-Gonçalves; Hervé Tettelin; David Lou; Stephanie Steiner; Tasmia Rezwanul; Qin Guo; William D Picking; Vishvanath Nene; Marcelo B Sztein
Journal:  PLoS Negl Trop Dis       Date:  2017-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.